IKESHIA KNIGHT: Open Payments
NPI 1710433495 · ROCKVILLE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$927 in 26 payments from 14 companies in 2025. Trend: 2023 $711 · 2024 $388 · 2025 $927
Food & beverage: $927
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 5 | $299 |
| Otsuka America Pharmaceutical, Inc. | 1 | $123 |
| Exact Sciences Corporation | 1 | $122 |
| Novo Nordisk Inc | 6 | $114 |
| Merck Sharp & Dohme LLC | 2 | $45 |
| ABBVIE INC. | 2 | $39 |
| PFIZER INC. | 2 | $32 |
| Astellas Pharma US Inc | 1 | $27 |
| Dexcom, Inc. | 1 | $27 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $26 |
Products named: BREZTRI, REXULTI, The Cologuard Plus Collection Kit, AIRSUPRA, GARDASIL 9, QULIPTA, Wegovy, Ozempic.
Industry payments across MD — which companies pay providers there.
